GDF5 therapeutic potential for Duchenne Muscular Dystrophy gene therapy optimization - Sorbonne Université Access content directly
Conference Papers Year : 2022

GDF5 therapeutic potential for Duchenne Muscular Dystrophy gene therapy optimization

France Piétri‐rouxel
Centre de recherche en Myologie – U974 SU-INSERM

Domains

Life Sciences [q-bio]
PRESENTATION Finale 300822.pdf (2.98 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

France Piétri-Rouxel  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-04000417

Submitted on : Monday, February 27, 2023-2:39:06 PM

Last modification on : Saturday, October 7, 2023-9:36:25 PM

Download

Dates and versions

hal-04000417 , version 1 (27-02-2023)

Identifiers

  • HAL Id : hal-04000417 , version 1

Cite

France Piétri‐rouxel. GDF5 therapeutic potential for Duchenne Muscular Dystrophy gene therapy optimization. 12th Japanese-French Workshop “New insights in personalized medicine for neuromuscular diseases: From Basic to Applied Myology”, Gisèle Bonne, Sep 2022, Giverny, France. ⟨hal-04000417⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

U974 SORBONNE-UNIVERSITE SU-MEDECINE U974-E5
7 View
23 Download

Share

Gmail Facebook X LinkedIn More